BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

452 related articles for article (PubMed ID: 15001781)

  • 1. A toll-like receptor that prevents infection by uropathogenic bacteria.
    Zhang D; Zhang G; Hayden MS; Greenblatt MB; Bussey C; Flavell RA; Ghosh S
    Science; 2004 Mar; 303(5663):1522-6. PubMed ID: 15001781
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tamm-Horsfall glycoprotein links innate immune cell activation with adaptive immunity via a Toll-like receptor-4-dependent mechanism.
    Säemann MD; Weichhart T; Zeyda M; Staffler G; Schunn M; Stuhlmeier KM; Sobanov Y; Stulnig TM; Akira S; von Gabain A; von Ahsen U; Hörl WH; Zlabinger GJ
    J Clin Invest; 2005 Feb; 115(2):468-75. PubMed ID: 15650774
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunology. After the toll rush.
    O'Neill LA
    Science; 2004 Mar; 303(5663):1481-2. PubMed ID: 15001768
    [No Abstract]   [Full Text] [Related]  

  • 4. [Frontier of mycobacterium research--host vs. mycobacterium].
    Okada M; Shirakawa T
    Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Uropathogenic Escherichia coli as a model of host-parasite interaction.
    Svanborg C; Bergsten G; Fischer H; Godaly G; Gustafsson M; Karpman D; Lundstedt AC; Ragnarsdottir B; Svensson M; Wullt B
    Curr Opin Microbiol; 2006 Feb; 9(1):33-9. PubMed ID: 16406777
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanism of pathogen-specific TLR4 activation in the mucosa: fimbriae, recognition receptors and adaptor protein selection.
    Fischer H; Yamamoto M; Akira S; Beutler B; Svanborg C
    Eur J Immunol; 2006 Feb; 36(2):267-77. PubMed ID: 16385628
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transcriptional activation induced in macrophages by Toll-like receptor (TLR) ligands: from expression profiling to a model of TLR signaling.
    Schmitz F; Mages J; Heit A; Lang R; Wagner H
    Eur J Immunol; 2004 Oct; 34(10):2863-73. PubMed ID: 15368303
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subversion of Toll-like receptor signaling by a unique family of bacterial Toll/interleukin-1 receptor domain-containing proteins.
    Cirl C; Wieser A; Yadav M; Duerr S; Schubert S; Fischer H; Stappert D; Wantia N; Rodriguez N; Wagner H; Svanborg C; Miethke T
    Nat Med; 2008 Apr; 14(4):399-406. PubMed ID: 18327267
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intracellular bacterial biofilm-like pods in urinary tract infections.
    Anderson GG; Palermo JJ; Schilling JD; Roth R; Heuser J; Hultgren SJ
    Science; 2003 Jul; 301(5629):105-7. PubMed ID: 12843396
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A live-attenuated vaccine for the treatment of urinary tract infection by uropathogenic Escherichia coli.
    Billips BK; Yaggie RE; Cashy JP; Schaeffer AJ; Klumpp DJ
    J Infect Dis; 2009 Jul; 200(2):263-72. PubMed ID: 19522648
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of Toll-like receptor signalling on urinary tract infection.
    Scherberich JE; Hartinger A
    Int J Antimicrob Agents; 2008 Feb; 31 Suppl 1():S9-14. PubMed ID: 17942281
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current concepts of molecular defence mechanisms operative during urinary tract infection.
    Weichhart T; Haidinger M; Hörl WH; Säemann MD
    Eur J Clin Invest; 2008 Oct; 38 Suppl 2():29-38. PubMed ID: 18826479
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antagonistic antibody prevents toll-like receptor 2-driven lethal shock-like syndromes.
    Meng G; Rutz M; Schiemann M; Metzger J; Grabiec A; Schwandner R; Luppa PB; Ebel F; Busch DH; Bauer S; Wagner H; Kirschning CJ
    J Clin Invest; 2004 May; 113(10):1473-81. PubMed ID: 15146245
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LRRC19, a novel member of the leucine-rich repeat protein family, activates NF-kappaB and induces expression of proinflammatory cytokines.
    Chai L; Dai L; Che Y; Xu J; Liu G; Zhang Z; Yang R
    Biochem Biophys Res Commun; 2009 Oct; 388(3):543-8. PubMed ID: 19679103
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathogen-specific TLR signaling in mucosa: mutual contribution of microbial TLR agonists and virulence factors.
    Sirard JC; Bayardo M; Didierlaurent A
    Eur J Immunol; 2006 Feb; 36(2):260-3. PubMed ID: 16453385
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction of uropathogenic Escherichia coli with host uroepithelium.
    Kau AL; Hunstad DA; Hultgren SJ
    Curr Opin Microbiol; 2005 Feb; 8(1):54-9. PubMed ID: 15694857
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of Toll-like receptor 2 on CD16+ blood monocytes and synovial tissue macrophages in rheumatoid arthritis.
    Iwahashi M; Yamamura M; Aita T; Okamoto A; Ueno A; Ogawa N; Akashi S; Miyake K; Godowski PJ; Makino H
    Arthritis Rheum; 2004 May; 50(5):1457-67. PubMed ID: 15146415
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neutrophil recruitment, chemokine receptors, and resistance to mucosal infection.
    Godaly G; Bergsten G; Hang L; Fischer H; Frendéus B; Lundstedt AC; Samuelsson M; Samuelsson P; Svanborg C
    J Leukoc Biol; 2001 Jun; 69(6):899-906. PubMed ID: 11404374
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Staphylococcus aureus and Escherichia coli cause deviating expression profiles of cytokines and lactoferrin messenger ribonucleic acid in mammary epithelial cells.
    Griesbeck-Zilch B; Meyer HH; Kühn CH; Schwerin M; Wellnitz O
    J Dairy Sci; 2008 Jun; 91(6):2215-24. PubMed ID: 18487644
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tamm-Horsfall protein: a multilayered defence molecule against urinary tract infection.
    Säemann MD; Weichhart T; Hörl WH; Zlabinger GJ
    Eur J Clin Invest; 2005 Apr; 35(4):227-35. PubMed ID: 15816991
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.